Alzamend Neuro, Inc.
ALZN· Nasdaq
ALZNAlzamend Neuro, Inc.
Filed Mar 10, 2025 · 10-Q · 38 days after period end · 0001214659-25-004123
| Metric | Q3 2025 | Q3 2024 | Q3 2023 | Q3 2022 |
|---|---|---|---|---|
| Net Income | -$1.04M | -$2.66M | -$5.43M | -$2.57M |
| EPS Diluted | -$0.19 | -$3.77 | -$0.83 | -$0.03 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Alzamend Neuro, Inc. · CIK 1677077 · Engraved from SEC EDGAR
ended Jan 31, 2025 · filed Mar 10, 2025 · 38 d after period end
